Mapping Global Prevalence of Acinetobacter baumannii and Recent Vaccine Development to Tackle It.
Ontology highlight
ABSTRACT: Acinetobacter baumannii is a leading cause of nosocomial infections that severely threaten public health. The formidable adaptability and resistance of this opportunistic pathogen have hampered the development of antimicrobial therapies which consequently leads to very limited treatment options. We mapped the global prevalence of multidrug-resistant A. baumannii and showed that carbapenem-resistant A. baumannii is widespread throughout Asia and the Americas. Moreover, when antimicrobial resistance rates of Acinetobacter spp. exceed a threshold level, the proportion of A. baumannii isolates from clinical samples surges. Therefore, vaccines represent a realistic alternative strategy to tackle this pathogen. Research into anti-A. baumannii vaccines ha
SUBMITTER: Ma C
PROVIDER: S-EPMC8226933 | biostudies-literature | 2021 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA